Press "Enter" to skip to content

New patent expiration for Astrazeneca Pharms drug PRILOSEC

0
Copyright © DrugPatentWatch. Originally published at New patent expiration for Astrazeneca Pharms drug PRILOSEC

Annual Drug Patent Expirations for PRILOSEC
Annual Drug Patent Expirations for PRILOSEC

Prilosec is a drug marketed by Astrazeneca Pharms and Covis Pharma Bv and is included in three NDAs. It is available from three suppliers. There are six patents protecting this drug and two Paragraph IV challenges.

Drug patent litigation for PRILOSEC.

This drug has twenty-one patent family members in nineteen countries.

The generic ingredient in PRILOSEC is omeprazole magnesium. Three suppliers are listed for this compound. Additional details are available on the omeprazole magnesium profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Copyright © DrugPatentWatch. Originally published at New patent expiration for Astrazeneca Pharms drug PRILOSEC
    Do NOT follow this link or you will be banned from the site!